カテゴリー： 世界, 部品/材料, LP Information

世界のコハク酸トレキサグリプチン市場予測 2023年-2029年

【英語タイトル】Global Trexagliptin Succinate Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07849）・商品コード：LP23DC07849
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のコハク酸トレキサグリプチン市場」は、過去の販売実績から2022年の世界のコハク酸トレキサグリプチンの総販売量を検討し、2023年から2029年の予測されるコハク酸トレキサグリプチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のコハク酸トレキサグリプチンの市場規模を掲載し、XXX百万米ドル規模の世界のコハク酸トレキサグリプチン市場の詳細な分析を提供します。本インサイトレポートは、世界のコハク酸トレキサグリプチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のコハク酸トレキサグリプチン市場における各社の独自のポジションをより深く理解するために、コハク酸トレキサグリプチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のコハク酸トレキサグリプチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。コハク酸トレキサグリプチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。コハク酸トレキサグリプチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。コハク酸トレキサグリプチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

コハク酸トレキサグリプチンの世界主要メーカーとしては、Kelun、 Takeda、 Manus Aktteva Biopharma LLP、 Ami Lifesciences、 Fortunachem、 Bulat Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のコハク酸トレキサグリプチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではコハク酸トレキサグリプチン市場をセグメンテーションし、種類別 (≧99.0%、≧99.9%)、用途別 (製薬、研究)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：≧99.0%、≧99.9%

・用途別区分：製薬、研究

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のコハク酸トレキサグリプチン市場の10年間の市場状況・展望は？
・世界および地域別に見たコハク酸トレキサグリプチン市場成長の要因は何か？
・コハク酸トレキサグリプチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・コハク酸トレキサグリプチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：コハク酸トレキサグリプチンの年間販売量2018-2029、地域別現状・将来分析
・コハク酸トレキサグリプチンの種類別セグメント：≧99.0%、≧99.9%
・コハク酸トレキサグリプチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・コハク酸トレキサグリプチンの用途別セグメント：製薬、研究
・コハク酸トレキサグリプチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のコハク酸トレキサグリプチン市場
・企業別のグローバルコハク酸トレキサグリプチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のコハク酸トレキサグリプチンの年間売上：2018-2023年の売上、市場シェア
・企業別のコハク酸トレキサグリプチン販売価格
・主要企業のコハク酸トレキサグリプチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

コハク酸トレキサグリプチンの地域別レビュー
・地域別のコハク酸トレキサグリプチン市場規模2018-2023：年間販売量、売上
・主要国別のコハク酸トレキサグリプチン市場規模2018-2023：年間販売量、売上
・南北アメリカのコハク酸トレキサグリプチン販売の成長
・アジア太平洋のコハク酸トレキサグリプチン販売の成長
・ヨーロッパのコハク酸トレキサグリプチン販売の成長
・中東・アフリカのコハク酸トレキサグリプチン販売の成長

南北アメリカ市場
・南北アメリカの国別のコハク酸トレキサグリプチン販売量、売上（2018-2023）
・南北アメリカのコハク酸トレキサグリプチンの種類別販売量
・南北アメリカのコハク酸トレキサグリプチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のコハク酸トレキサグリプチン販売量、売上（2018-2023）
・アジア太平洋のコハク酸トレキサグリプチンの種類別販売量
・アジア太平洋のコハク酸トレキサグリプチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のコハク酸トレキサグリプチン販売量、売上（2018-2023）
・ヨーロッパのコハク酸トレキサグリプチンの種類別販売量
・ヨーロッパのコハク酸トレキサグリプチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のコハク酸トレキサグリプチン販売量、売上（2018-2023）
・中東・アフリカのコハク酸トレキサグリプチンの種類別販売量
・中東・アフリカのコハク酸トレキサグリプチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・コハク酸トレキサグリプチンの製造コスト構造分析
・コハク酸トレキサグリプチンの製造プロセス分析
・コハク酸トレキサグリプチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・コハク酸トレキサグリプチンの主要なグローバル販売業者
・コハク酸トレキサグリプチンの主要なグローバル顧客

地域別のコハク酸トレキサグリプチン市場予測レビュー
・地域別のコハク酸トレキサグリプチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・コハク酸トレキサグリプチンの種類別市場規模予測
・コハク酸トレキサグリプチンの用途別市場規模予測

主要企業分析
Kelun、 Takeda、 Manus Aktteva Biopharma LLP、 Ami Lifesciences、 Fortunachem、 Bulat Pharmaceutical
・企業情報
・コハク酸トレキサグリプチン製品
・コハク酸トレキサグリプチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Trexagliptin Succinate market size is projected to grow from US$ 1076.1 million in 2022 to US$ 5101.6 million in 2029; it is expected to grow at a CAGR of 24.9% from 2023 to 2029.
The pharmaceutical industry continues to expand, driven by factors such as increasing healthcare spending, advancements in drug development, and an aging population. This expansion presents opportunities for the development and commercialization of new drugs such as trexagliptin succinate.
Trelagliptin Succinate is a fluorinated derivative of Alogliptin, which treats Type-2 Diabetes. It is a highly selective Dipeptidyl Peptidase -4 inhibitor that activates the T-cells. Trelagliptin Succinate has a chemical formula of C22H26FN5O6 and is also represented as SYR 111472 succinate.
LPI (LP Information)’ newest research report, the “Trexagliptin Succinate Industry Forecast” looks at past sales and reviews total world Trexagliptin Succinate sales in 2022, providing a comprehensive analysis by region and market sector of projected Trexagliptin Succinate sales for 2023 through 2029. With Trexagliptin Succinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trexagliptin Succinate industry.
This Insight Report provides a comprehensive analysis of the global Trexagliptin Succinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trexagliptin Succinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Trexagliptin Succinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trexagliptin Succinate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trexagliptin Succinate.
This report presents a comprehensive overview, market shares, and growth opportunities of Trexagliptin Succinate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
≥99.0%
≥99.9%
Segmentation by application
Pharmaceutical
Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Kelun
Takeda
Manus Aktteva Biopharma LLP
Ami Lifesciences
Fortunachem
Bulat Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Trexagliptin Succinate market?
What factors are driving Trexagliptin Succinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Trexagliptin Succinate market opportunities vary by end market size?
How does Trexagliptin Succinate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Trexagliptin Succinate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Trexagliptin Succinate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Trexagliptin Succinate by Country/Region, 2018, 2022 & 2029
2.2 Trexagliptin Succinate Segment by Type
2.2.1 ≥99.0%
2.2.2 ≥99.9%
2.3 Trexagliptin Succinate Sales by Type
2.3.1 Global Trexagliptin Succinate Sales Market Share by Type (2018-2023)
2.3.2 Global Trexagliptin Succinate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Trexagliptin Succinate Sale Price by Type (2018-2023)
2.4 Trexagliptin Succinate Segment by Application
2.4.1 Pharmaceutical
2.4.2 Research
2.5 Trexagliptin Succinate Sales by Application
2.5.1 Global Trexagliptin Succinate Sale Market Share by Application (2018-2023)
2.5.2 Global Trexagliptin Succinate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Trexagliptin Succinate Sale Price by Application (2018-2023)
3 Global Trexagliptin Succinate by Company
3.1 Global Trexagliptin Succinate Breakdown Data by Company
3.1.1 Global Trexagliptin Succinate Annual Sales by Company (2018-2023)
3.1.2 Global Trexagliptin Succinate Sales Market Share by Company (2018-2023)
3.2 Global Trexagliptin Succinate Annual Revenue by Company (2018-2023)
3.2.1 Global Trexagliptin Succinate Revenue by Company (2018-2023)
3.2.2 Global Trexagliptin Succinate Revenue Market Share by Company (2018-2023)
3.3 Global Trexagliptin Succinate Sale Price by Company
3.4 Key Manufacturers Trexagliptin Succinate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trexagliptin Succinate Product Location Distribution
3.4.2 Players Trexagliptin Succinate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Trexagliptin Succinate by Geographic Region
4.1 World Historic Trexagliptin Succinate Market Size by Geographic Region (2018-2023)
4.1.1 Global Trexagliptin Succinate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Trexagliptin Succinate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Trexagliptin Succinate Market Size by Country/Region (2018-2023)
4.2.1 Global Trexagliptin Succinate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Trexagliptin Succinate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Trexagliptin Succinate Sales Growth
4.4 APAC Trexagliptin Succinate Sales Growth
4.5 Europe Trexagliptin Succinate Sales Growth
4.6 Middle East & Africa Trexagliptin Succinate Sales Growth
5 Americas
5.1 Americas Trexagliptin Succinate Sales by Country
5.1.1 Americas Trexagliptin Succinate Sales by Country (2018-2023)
5.1.2 Americas Trexagliptin Succinate Revenue by Country (2018-2023)
5.2 Americas Trexagliptin Succinate Sales by Type
5.3 Americas Trexagliptin Succinate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trexagliptin Succinate Sales by Region
6.1.1 APAC Trexagliptin Succinate Sales by Region (2018-2023)
6.1.2 APAC Trexagliptin Succinate Revenue by Region (2018-2023)
6.2 APAC Trexagliptin Succinate Sales by Type
6.3 APAC Trexagliptin Succinate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Trexagliptin Succinate by Country
7.1.1 Europe Trexagliptin Succinate Sales by Country (2018-2023)
7.1.2 Europe Trexagliptin Succinate Revenue by Country (2018-2023)
7.2 Europe Trexagliptin Succinate Sales by Type
7.3 Europe Trexagliptin Succinate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Trexagliptin Succinate by Country
8.1.1 Middle East & Africa Trexagliptin Succinate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Trexagliptin Succinate Revenue by Country (2018-2023)
8.2 Middle East & Africa Trexagliptin Succinate Sales by Type
8.3 Middle East & Africa Trexagliptin Succinate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trexagliptin Succinate
10.3 Manufacturing Process Analysis of Trexagliptin Succinate
10.4 Industry Chain Structure of Trexagliptin Succinate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trexagliptin Succinate Distributors
11.3 Trexagliptin Succinate Customer
12 World Forecast Review for Trexagliptin Succinate by Geographic Region
12.1 Global Trexagliptin Succinate Market Size Forecast by Region
12.1.1 Global Trexagliptin Succinate Forecast by Region (2024-2029)
12.1.2 Global Trexagliptin Succinate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Trexagliptin Succinate Forecast by Type
12.7 Global Trexagliptin Succinate Forecast by Application
13 Key Players Analysis
13.1 Kelun
13.1.1 Kelun Company Information
13.1.2 Kelun Trexagliptin Succinate Product Portfolios and Specifications
13.1.3 Kelun Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Kelun Main Business Overview
13.1.5 Kelun Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Trexagliptin Succinate Product Portfolios and Specifications
13.2.3 Takeda Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Manus Aktteva Biopharma LLP
13.3.1 Manus Aktteva Biopharma LLP Company Information
13.3.2 Manus Aktteva Biopharma LLP Trexagliptin Succinate Product Portfolios and Specifications
13.3.3 Manus Aktteva Biopharma LLP Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Manus Aktteva Biopharma LLP Main Business Overview
13.3.5 Manus Aktteva Biopharma LLP Latest Developments
13.4 Ami Lifesciences
13.4.1 Ami Lifesciences Company Information
13.4.2 Ami Lifesciences Trexagliptin Succinate Product Portfolios and Specifications
13.4.3 Ami Lifesciences Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ami Lifesciences Main Business Overview
13.4.5 Ami Lifesciences Latest Developments
13.5 Fortunachem
13.5.1 Fortunachem Company Information
13.5.2 Fortunachem Trexagliptin Succinate Product Portfolios and Specifications
13.5.3 Fortunachem Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Fortunachem Main Business Overview
13.5.5 Fortunachem Latest Developments
13.6 Bulat Pharmaceutical
13.6.1 Bulat Pharmaceutical Company Information
13.6.2 Bulat Pharmaceutical Trexagliptin Succinate Product Portfolios and Specifications
13.6.3 Bulat Pharmaceutical Trexagliptin Succinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bulat Pharmaceutical Main Business Overview
13.6.5 Bulat Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Trexagliptin Succinate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Trexagliptin Succinate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of ≥99.0%
Table 4. Major Players of ≥99.9%
Table 5. Global Trexagliptin Succinate Sales by Type (2018-2023) & (Tons)
Table 6. Global Trexagliptin Succinate Sales Market Share by Type (2018-2023)
Table 7. Global Trexagliptin Succinate Revenue by Type (2018-2023) & ($ million)
Table 8. Global Trexagliptin Succinate Revenue Market Share by Type (2018-2023)
Table 9. Global Trexagliptin Succinate Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Trexagliptin Succinate Sales by Application (2018-2023) & (Tons)
Table 11. Global Trexagliptin Succinate Sales Market Share by Application (2018-2023)
Table 12. Global Trexagliptin Succinate Revenue by Application (2018-2023)
Table 13. Global Trexagliptin Succinate Revenue Market Share by Application (2018-2023)
Table 14. Global Trexagliptin Succinate Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Trexagliptin Succinate Sales by Company (2018-2023) & (Tons)
Table 16. Global Trexagliptin Succinate Sales Market Share by Company (2018-2023)
Table 17. Global Trexagliptin Succinate Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Trexagliptin Succinate Revenue Market Share by Company (2018-2023)
Table 19. Global Trexagliptin Succinate Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Trexagliptin Succinate Producing Area Distribution and Sales Area
Table 21. Players Trexagliptin Succinate Products Offered
Table 22. Trexagliptin Succinate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Trexagliptin Succinate Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Trexagliptin Succinate Sales Market Share Geographic Region (2018-2023)
Table 27. Global Trexagliptin Succinate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Trexagliptin Succinate Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Trexagliptin Succinate Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Trexagliptin Succinate Sales Market Share by Country/Region (2018-2023)
Table 31. Global Trexagliptin Succinate Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Trexagliptin Succinate Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Trexagliptin Succinate Sales by Country (2018-2023) & (Tons)
Table 34. Americas Trexagliptin Succinate Sales Market Share by Country (2018-2023)
Table 35. Americas Trexagliptin Succinate Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Trexagliptin Succinate Revenue Market Share by Country (2018-2023)
Table 37. Americas Trexagliptin Succinate Sales by Type (2018-2023) & (Tons)
Table 38. Americas Trexagliptin Succinate Sales by Application (2018-2023) & (Tons)
Table 39. APAC Trexagliptin Succinate Sales by Region (2018-2023) & (Tons)
Table 40. APAC Trexagliptin Succinate Sales Market Share by Region (2018-2023)
Table 41. APAC Trexagliptin Succinate Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Trexagliptin Succinate Revenue Market Share by Region (2018-2023)
Table 43. APAC Trexagliptin Succinate Sales by Type (2018-2023) & (Tons)
Table 44. APAC Trexagliptin Succinate Sales by Application (2018-2023) & (Tons)
Table 45. Europe Trexagliptin Succinate Sales by Country (2018-2023) & (Tons)
Table 46. Europe Trexagliptin Succinate Sales Market Share by Country (2018-2023)
Table 47. Europe Trexagliptin Succinate Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Trexagliptin Succinate Revenue Market Share by Country (2018-2023)
Table 49. Europe Trexagliptin Succinate Sales by Type (2018-2023) & (Tons)
Table 50. Europe Trexagliptin Succinate Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Trexagliptin Succinate Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Trexagliptin Succinate Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Trexagliptin Succinate Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Trexagliptin Succinate Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Trexagliptin Succinate Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Trexagliptin Succinate Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Trexagliptin Succinate
Table 58. Key Market Challenges & Risks of Trexagliptin Succinate
Table 59. Key Industry Trends of Trexagliptin Succinate
Table 60. Trexagliptin Succinate Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Trexagliptin Succinate Distributors List
Table 63. Trexagliptin Succinate Customer List
Table 64. Global Trexagliptin Succinate Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Trexagliptin Succinate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Trexagliptin Succinate Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Trexagliptin Succinate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Trexagliptin Succinate Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Trexagliptin Succinate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Trexagliptin Succinate Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Trexagliptin Succinate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Trexagliptin Succinate Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Trexagliptin Succinate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Trexagliptin Succinate Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Trexagliptin Succinate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Trexagliptin Succinate Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Trexagliptin Succinate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Kelun Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 79. Kelun Trexagliptin Succinate Product Portfolios and Specifications
Table 80. Kelun Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Kelun Main Business
Table 82. Kelun Latest Developments
Table 83. Takeda Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Trexagliptin Succinate Product Portfolios and Specifications
Table 85. Takeda Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. Manus Aktteva Biopharma LLP Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 89. Manus Aktteva Biopharma LLP Trexagliptin Succinate Product Portfolios and Specifications
Table 90. Manus Aktteva Biopharma LLP Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Manus Aktteva Biopharma LLP Main Business
Table 92. Manus Aktteva Biopharma LLP Latest Developments
Table 93. Ami Lifesciences Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 94. Ami Lifesciences Trexagliptin Succinate Product Portfolios and Specifications
Table 95. Ami Lifesciences Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Ami Lifesciences Main Business
Table 97. Ami Lifesciences Latest Developments
Table 98. Fortunachem Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 99. Fortunachem Trexagliptin Succinate Product Portfolios and Specifications
Table 100. Fortunachem Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Fortunachem Main Business
Table 102. Fortunachem Latest Developments
Table 103. Bulat Pharmaceutical Basic Information, Trexagliptin Succinate Manufacturing Base, Sales Area and Its Competitors
Table 104. Bulat Pharmaceutical Trexagliptin Succinate Product Portfolios and Specifications
Table 105. Bulat Pharmaceutical Trexagliptin Succinate Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Bulat Pharmaceutical Main Business
Table 107. Bulat Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Trexagliptin Succinate
Figure 2. Trexagliptin Succinate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trexagliptin Succinate Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Trexagliptin Succinate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Trexagliptin Succinate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of ≥99.0%
Figure 10. Product Picture of ≥99.9%
Figure 11. Global Trexagliptin Succinate Sales Market Share by Type in 2022
Figure 12. Global Trexagliptin Succinate Revenue Market Share by Type (2018-2023)
Figure 13. Trexagliptin Succinate Consumed in Pharmaceutical
Figure 14. Global Trexagliptin Succinate Market: Pharmaceutical (2018-2023) & (Tons)
Figure 15. Trexagliptin Succinate Consumed in Research
Figure 16. Global Trexagliptin Succinate Market: Research (2018-2023) & (Tons)
Figure 17. Global Trexagliptin Succinate Sales Market Share by Application (2022)
Figure 18. Global Trexagliptin Succinate Revenue Market Share by Application in 2022
Figure 19. Trexagliptin Succinate Sales Market by Company in 2022 (Tons)
Figure 20. Global Trexagliptin Succinate Sales Market Share by Company in 2022
Figure 21. Trexagliptin Succinate Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Trexagliptin Succinate Revenue Market Share by Company in 2022
Figure 23. Global Trexagliptin Succinate Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Trexagliptin Succinate Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Trexagliptin Succinate Sales 2018-2023 (Tons)
Figure 26. Americas Trexagliptin Succinate Revenue 2018-2023 ($ Millions)
Figure 27. APAC Trexagliptin Succinate Sales 2018-2023 (Tons)
Figure 28. APAC Trexagliptin Succinate Revenue 2018-2023 ($ Millions)
Figure 29. Europe Trexagliptin Succinate Sales 2018-2023 (Tons)
Figure 30. Europe Trexagliptin Succinate Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Trexagliptin Succinate Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Trexagliptin Succinate Revenue 2018-2023 ($ Millions)
Figure 33. Americas Trexagliptin Succinate Sales Market Share by Country in 2022
Figure 34. Americas Trexagliptin Succinate Revenue Market Share by Country in 2022
Figure 35. Americas Trexagliptin Succinate Sales Market Share by Type (2018-2023)
Figure 36. Americas Trexagliptin Succinate Sales Market Share by Application (2018-2023)
Figure 37. United States Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Trexagliptin Succinate Sales Market Share by Region in 2022
Figure 42. APAC Trexagliptin Succinate Revenue Market Share by Regions in 2022
Figure 43. APAC Trexagliptin Succinate Sales Market Share by Type (2018-2023)
Figure 44. APAC Trexagliptin Succinate Sales Market Share by Application (2018-2023)
Figure 45. China Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Trexagliptin Succinate Sales Market Share by Country in 2022
Figure 53. Europe Trexagliptin Succinate Revenue Market Share by Country in 2022
Figure 54. Europe Trexagliptin Succinate Sales Market Share by Type (2018-2023)
Figure 55. Europe Trexagliptin Succinate Sales Market Share by Application (2018-2023)
Figure 56. Germany Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Trexagliptin Succinate Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Trexagliptin Succinate Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Trexagliptin Succinate Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Trexagliptin Succinate Sales Market Share by Application (2018-2023)
Figure 65. Egypt Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Trexagliptin Succinate Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Trexagliptin Succinate in 2022
Figure 71. Manufacturing Process Analysis of Trexagliptin Succinate
Figure 72. Industry Chain Structure of Trexagliptin Succinate
Figure 73. Channels of Distribution
Figure 74. Global Trexagliptin Succinate Sales Market Forecast by Region (2024-2029)
Figure 75. Global Trexagliptin Succinate Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Trexagliptin Succinate Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Trexagliptin Succinate Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Trexagliptin Succinate Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Trexagliptin Succinate Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のコハク酸トレキサグリプチン市場予測 2023年-2029年] (コード：LP23DC07849)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のコハク酸トレキサグリプチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のポリブチレンサクシネート樹脂市場予測 2023年-2029年
  • 世界のバイオポリマープラスチック市場予測 2023年-2029年
  • 世界のサステナブルプラスチック製包装市場予測 2023年-2029年
  • 世界のピリベディル市場予測 2023年-2029年
  • 世界のシクロゲラン酸メチル市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆